Spectrum Pharmaceuticals Inc

SPPICIK 0000831547 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0001

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Spectrum Pharmaceuticals Inc

Name	Roles	Filings
McGahan Keith M	Officer	8
Riga Thomas J	OfficerDirector	8
Brennan Nora	Officer	4
Lebel Francois	Officer	4
Ashton William	Director	2

Showing 1-5 of 11

Per pagePage 1 of 3Next

All filings

36 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 17, 2023	McGahan Keith M Chief Legal Officer	SSale	27,197	$0.796	$21,649
Feb 24, 2023	Riga Thomas J CEO & President · Director	SSale	22,402	$0.77	$17,250
Feb 24, 2023	McGahan Keith M Chief Legal Officer	SSale	18,385	$0.77	$14,156
Feb 1, 2023	Riga Thomas J CEO & President · Director	SSale	107,424	$0.66	$70,900
Feb 1, 2023	McGahan Keith M Chief Legal Officer	SSale	41,014	$0.62	$25,429

Showing 11-15 of 36

Per pagePrevPage 3 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value